Frozen water phase method for logD measurement using a 96-well plate

Talanta

Volumn 84, Issue 3, 2011, Pages 809-813

  Yamashita, Taro ^a   Yamamoto, Eiichi ^a   Kushida, Ikuo ^a  

^a EISAI CO LTD   (Japan)

Author keywords

1 Octanol; Frozen water phase method; Liquid nitrogen; logD; Physical property; Physicochemical screening

Indexed keywords

CHEMICAL ANALYSIS; CHEMISTRY; PHYSICAL PROPERTIES;

1-OCTANOL; 96-WELL PLATE; FROZEN WATER; LIPOPHILIC COMPOUNDS; LOGD; PHASE CONTAMINATION; WATER PHASE; WIDE DYNAMIC RANGE;

LIQUID NITROGEN;

EID: 79954415467     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2011.02.015     Document Type: Article

References (29)

1. I. Shamovsky, S. Connolly, L. David, S. Ivanova, B. Norden, B. Springthrope, K. Urbahns, J. Med. Chem. 51 (2008) 1162-1178.
2. Y.C. Martin, J. Med. Chem. 48 (2005) 3164-3170.
3. M. Ishigami, T. Honda, W. Takasaki, T. Ikeda, T. Komai, K. Ito, Y. Sugiyama, Drug Metab. Dispos. 29 (2001) 282-288.
4. X. Liu, M. Tu, R.S. Kelly, C. Chen, B.J. Smith, Drug Metab. Dispos. 32 (2004) 132-139.
5. E.H. Kerns, L. Di, Drug Discov. Today Technol. 1 (2004) 343-348.
6. C.A. Lipinski, J. Pharmacol. Toxicol. Methods 44 (2000) 235-249.
7. H.V.D. Waterbeemd, D.A. Smith, K. Beaumont, D.K. Walker, J. Med. Chem. 44 (2001) 1313-1333.
8. Z. Chen, S.G. Weber, Anal. Chem. 79 (2007) 1043-1049.
9. T. Hartmann, J. Schmitt, C. Rohring, D. Nimptsch, J. Noller, C. Mohr, Curr. Drug Deliv. 3 (2006) 181-192.
10. S.M. Ulmeanu, H. Jensen, G. Bouchard, P.-A. Carrupt, H.H. Girault, Pharm. Res. (2003) 1317-1322.
11. H.V.D. Waterbeemd, H. Lennernas, P. Artursson, R. Mannhold, H. Kubinyi, G. Folkers (Eds.), Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, Wiley-VCH Verlag GmbH Inc., Weinheim, Germany, 2003, pp. 3-242.
12. A. Avdeef, Curr. Top. Med. Chem. 1 (2001) 277-351.
13. K. Valko, J. Chromatogr. A 1037 (2004) 299-310.
14. R. Kaliszan, P. Haber, T. Baczek, D. Siluk, K. Valko, J. Chromatogr. A 965 (2002) 117-127.
15. K. Valko, P. Slegel, J. Chromatogr. A 631 (1993) 49-61.
16. M. Alimuddin, D. Grant, D. Bulloch, N. Lee, M. Peacock, R. Dahl, J. Med. Chem.51 (2008) 5140-5142.
17. P.C. Chiang, Y. Hu, Comb. Chem. High Throughput Screen. 12 (2009) 250-257.
18. Y. Dohta, T. Yamashita, S. Horiike, T. Nakamura, T. Fukami, Anal.Chem.79(2007) 8312-8315.
19. T. Yamashita, I. Nishimura, T. Nakamura, T. Fukami, JALA 14 (2009) 76-81.
20. Y.W. Alelyunas, L. Pelosi-Kilby, P. Turcotte, M.B. Kary, R.C. Spreen, J. Chromatogr. A 1217 (2010) 1950-1955.
21. I. Nishimura, A. Hirano, T. Yamashita, T. Fukami, J. Chromatogr. A 1216 (2009) 2984-2988.
22. S.R.C.J. Santos, E.V. Campos, C. Sanches, D.S. Gomez, M.C. Ferreira, CLINICS 65 (2010) 237-243.
23. C.M. Fernandez, V.C. Martin, Talanta 24 (1977) 747-748.
24. K. Sugano, H. Hamada, M. Machida, H. Ushio, J. Biomol. Screen. 6 (2001) 189-196.
25. The Merck Index, Twelfth edition, Merck & CO. Inc., Whitehouse Station, New Jersey, 1996, pp 1160-1161.
26. F. Lombardo, M.Y. Shalaeva, K.A. Tupper, F. Gao, J. Med. Chem. 44 (2001) 2490-2497.
27. M.I.L. Rotonda, G. Amato, F. Barbato, C. Silipo, A. Vittoria, Quant. Struct. Act. Relat. 2 (1983) 168-173.
28. A. Avdeef, Absorption and Drug Development: Solubility, Permeability, and Charge State, John Wiley & Sons Inc., Hoboken, New Jersey, 2003, pp. 23-66.
29. E.H. Kerns, L. Di, Drug-like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, Elsevier Inc., London, UK, 2008, p. 45.